Early research (Phase 1)UnknownNCT03464032What this trial is testingBCD-135 in Patients With Advanced Solid TumorsWho this might be right forMelanomaNSCLCRenal Cell Carcinoma+1 more Biocad 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07551778What this trial is testingAllogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid TumorsWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)Colorectal CancerAdvanced Solid Tumors+2 more BOE Technology Group Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT04863248What this trial is testingTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)Who this might be right forMetastatic Non-Small Cell Lung CancerNSCLCLung Cancer G1 Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07124793What this trial is testingIBI363 Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forEGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer Innovent Biologics (Suzhou) Co. Ltd. 60
Early research (Phase 1)Study completedNCT04306900What this trial is testingTTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersWho this might be right forSolid Tumor, Adult Trishula Therapeutics, Inc. 185
Testing effectiveness (Phase 2)Looking for participantsNCT04977453What this trial is testingGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more GI Innovation, Inc. 317
Early research (Phase 1)Active Not RecruitingNCT05789069What this trial is testingHFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsWho this might be right forRenal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more HiFiBiO Therapeutics 83
Early research (Phase 1)Study completedNCT02043665What this trial is testingCVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)Who this might be right forNon-small Cell Lung CancerBladder Cancer Viralytics 85
Early research (Phase 1)Not Yet RecruitingNCT05940116What this trial is testingA Phase I Clinical Study of HS-20117 in Participants With Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerSolid Tumor Hansoh BioMedical R&D Company 322
Early research (Phase 1)Looking for participantsNCT07444814What this trial is testingStudy Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsWho this might be right forEndometrial CancerOvarian CancerOvarian Cancer Metastatic+4 more Whitehawk Therapeutics, Inc. 226
Testing effectiveness (Phase 2)Study completedNCT00514215What this trial is testingCryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung CancerWho this might be right forKidney CancerLung CancerMetastatic Cancer+1 more Barbara Ann Karmanos Cancer Institute 8
Early research (Phase 1)Looking for participantsNCT07277413What this trial is testingIDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsWho this might be right forNSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Ended earlyNCT02805660What this trial is testingPhase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLCWho this might be right forAdvanced Cancer Mirati Therapeutics Inc. 83
Early research (Phase 1)Study completedNCT00635791What this trial is testingPhase I Study of Vorinostat and Sorafenib in Advanced CancerWho this might be right forMalignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma University of Colorado, Denver 36
Early research (Phase 1)Looking for participantsNCT06792552What this trial is testingA Phase I Study of SIM0505 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more NextCure, Inc. 738
Testing effectiveness (Phase 2)Study completedNCT03744468What this trial is testingStudy of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-inHNSCC for Phase 2 Dose ExpansionNSCLC for Phase 2 Dose Expansion BeiGene 147
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Looking for participantsNCT07801508What this trial is testing[68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsWho this might be right forAdvanced Gastroesophageal AdenocarcinomaAdvanced Breast CancerTriple-negative Breast Cancer+1 more Novartis Pharmaceuticals 66
Early research (Phase 1)Study completedNCT01570296What this trial is testingA Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRWho this might be right forNon-Small Cell Lung CancerSolid Tumors National Cancer Centre, Singapore 38
Early research (Phase 1)WithdrawnNCT01383668What this trial is testingSirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+3 more Mayo Clinic